Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLM-Study: Combination of Olmesartan and CCB or Diuretics in Elderly Hypertensive Patients
NCT00454662Phase 4Completed
- Sponsor
- COLM Study Research Organization
- Start
- Apr 2007
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of olmesartan in hypertension (HTN) (2 arms), sponsored by COLM Study Research Organization. Primary endpoint: Composite of fatal and non-fatal cardiovascular events. Started Apr 2007; status: completed.
02
Drugs
olmesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00454662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00454662.